STOCK TITAN

Routine RSU Grant Boosts BKV Director Sunit Patel’s Stake to 55.8K Shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BKV Corp (ticker: BKV) filed a Form 4 on 20 Jun 2025 disclosing an equity award to non-employee director Sunit S. Patel. On 19 Jun 2025 Mr. Patel received 5,761 restricted stock units (RSUs) at a grant price of $0 as part of the company’s standard non-employee director compensation program. Each RSU converts into one share of BKV common stock when vested.

The RSUs vest in full on the day prior to the 2026 annual shareholder meeting, providing roughly a one-year service and performance horizon. Following the grant, Mr. Patel’s total beneficial ownership increased to 55,761 shares, all held directly. No derivative securities or sales were reported, and the filing makes no reference to a Rule 10b5-1 trading plan.

From an investor perspective, the transaction is routine board compensation with immaterial dilution and no immediate cash impact on the company. It modestly aligns director incentives with shareholder value creation but does not signal a change in strategic outlook or financial condition. The filing satisfies Section 16 reporting requirements and carries no additional earnings data or operational disclosures.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine RSU grant to director; negligible financial impact, neutral signal.

The award of 5,761 RSUs, vesting ahead of the 2026 AGM, is standard board remuneration. The share count is immaterial relative to BKV’s outstanding float, thus dilution is de minimis. No open-market purchase or sale occurred, so the transaction does not provide directional insight into insider sentiment. The filing is timely and fulfils Section 16 obligations, reflecting ordinary governance practice rather than a catalyst for valuation change.

TL;DR: Grant strengthens pay-for-service alignment; governance neutral.

Issuing time-based RSUs to non-employee directors keeps compensation equity-weighted, fostering alignment with long-term shareholder interests. The vesting horizon of about one year is consistent with prevailing mid-cap governance standards, though extending vesting further could deepen alignment. No red flags arise regarding trading plans or accelerated vesting. Overall, the filing is routine and carries no material governance concerns.

Insider PATEL SUNIT S
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 5,761 $0.00 --
Holdings After Transaction: Common Stock — 55,761 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PATEL SUNIT S

(Last) (First) (Middle)
1200 17TH STREET, SUITE 2100

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/19/2025 A 5,761(1) A $0 55,761 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units granted to the reporting person under the Issuer's non-employee director compensation program that vest the day prior to Issuer's 2026 annual stockholder meeting. Each restricted stock unit represents a contingent right to receive one share of Common Stock.
Remarks:
/s/ Kathleen Lenox, attorney-in-fact 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many BKV shares did director Sunit S. Patel acquire?

5,761 restricted stock units were granted, each convertible into one common share.

What is the vesting schedule for the newly granted RSUs?

The RSUs vest one day before the 2026 annual shareholder meeting.

What is Sunit Patel’s total beneficial ownership after the transaction?

After the grant, Mr. Patel beneficially owns 55,761 BKV shares.

Was the transaction part of a Rule 10b5-1 trading plan?

The filing does not indicate that a Rule 10b5-1 plan was used.

Did the Form 4 report any open-market purchases or sales of BKV stock?

No; the filing reports only a grant of RSUs, with no purchases or sales.